Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Aug 6, 2026 04:05PM

CONSHOHOCKEN, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on August 1, 2026 to ten new non-executive employees as equity inducement awards under the terms of Madrigal’s 2025 Inducement Plan. The equity awards were approved by Madrigal’s independent... (continue reading...)


Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results Aug 6, 2026 04:05PM
  • August 25, 2026 U.S. PDUFA target action date for zanidatamab has potential to unlock a $250 million U.S. approval milestone and up to $190 million in potential additional global regulatory milestones
  • Acquisition of Theravance Biopharma, Inc. expected to close in 2H 2026, adding durable commercial cash flows and expanding Zymeworks' diversified revenue base
  • Continued advancement of R&D pipeline across wholly-owned and partnered programs
  • Repurchased $49.4 million of common... (continue reading...)

El Pollo Loco Holdings, Inc. Announces Second Quarter 2026 Financial Results Aug 6, 2026 04:05PM

Delivers 3.9% System-wide Comparable Restaurant SalesRaises 2026 Full-Year Outlook

COSTA MESA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) (the “Company”) today announced financial results for the 13-week period ended July 1, 2026.

Highlights for the second quarter ended July 1, 2026 compared to the second quarter ended June 25, 2025 were as follows:


SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates Aug 6, 2026 04:05PM
  • Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of enrollment expected in 2027.
  • Bimatoprost-Drug Ring System (BIM-DRS) first-in-human trial is on track to start in the second half of 2026.
  • Cash, cash equivalents and short-term investments of $234.2 million on June 30, 2026, are expected to fund planned operations through 2028.

IRVINE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) --... (continue reading...)


Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates Aug 6, 2026 04:05PM
  • Following U.S. regulatory discussions, accelerated approval strategy remains intact, supported by DENALI Part 2
  • Enrollment completed in Part 2a and 2b of the DENALI trial; Part 2c is enrolling
  • DENALI Part 2 topline readout expected in 1H 2027 to allow for data maturation post full enrollment
  • $174.6 million in cash, cash equivalents and marketable securities as of June 30, 2026, providing runway into late 2027 to support execution of key milestones

SAN DIEGO, Aug. 06,... (continue reading...)


More Globe Newswire

View Older Stories

Aug 6, 2026 04:05PM Cerence AI Reports Third Quarter Results: Revenue Up 12% YoY, Connected Services Revenue Up 20% YoY; Operating Cash Flow of $20M Supports First-Ever Share Repurchase Program
Aug 6, 2026 04:05PM The Joint Corp. Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Bridger Aerospace Reports Second Quarter 2026 Results
Aug 6, 2026 04:05PM Fidus Investment Corporation Announces Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Artesian Resources Corporation Reports Second Quarter and Year-To-Date 2026 Results
Aug 6, 2026 04:05PM Nature's Sunshine Reports Second Quarter 2026 Results
Aug 6, 2026 04:05PM Apyx Medical Corporation Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM SkinHealth Systems Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Runway Growth Finance Corp. Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM iRhythm Holdings Announces Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM ARKO Petroleum Corp Announces Agreement to Acquire the Business of U.S. Petroleum Partners, LLC (“USPP”), a Vertically Integrated Fuel Supply and Distribution Platform Expected to Increase Annual
Aug 6, 2026 04:06PM ARKO Petroleum Corp. Reports Second Quarter 2026 Results
Aug 6, 2026 04:05PM ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
Aug 6, 2026 04:05PM CarGurus Announces Second Quarter 2026 Results
Aug 6, 2026 04:06PM iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
Aug 6, 2026 04:05PM Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026 04:05PM Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Mobile Infrastructure Announces Receipt of a Preliminary, Non-Binding Indication of Interest from Bombe Asset Management
Aug 6, 2026 04:05PM Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026 04:05PM Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended June 30, 2026, Declares Third Quarter 2026 Dividend of $0.35 Per Common Share
Aug 6, 2026 04:05PM Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 6, 2026 04:05PM Fox Factory Holding Corp. Reports Second Quarter Fiscal 2026 Financial Results
Aug 6, 2026 04:05PM Altus Group Reports Q2 2026 Financial Results & Quarterly Dividend
Aug 6, 2026 04:05PM Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026
Aug 6, 2026 04:05PM Quest Resource Holding Corporation Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM CVRx Reports Second Quarter 2026 Financial and Operating Results
Aug 6, 2026 04:05PM Rigetti Computing Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026 04:05PM Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026 04:05PM electroCore Announces Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Tyson Foods Announces Quarterly Dividend
Aug 6, 2026 04:05PM Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Altus Group Reports Q2 2026 Financial Results & Quarterly Dividend
Aug 6, 2026 04:05PM AerSale Reports Second Quarter 2026 Results
Aug 6, 2026 04:05PM Red Cat Reports Q2 2026 Revenue Growth of 527% Y/Y; Q2 Gross Margins Increase 39% vs Q2 2025; Gross Margins Increased 27% Sequentially from Q1 2026
Aug 6, 2026 04:05PM AMD Acquires Taalas to Advance Compute Solutions for Rapidly Growing AI Inference Market
Aug 6, 2026 04:05PM Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM MARA Announces Second Quarter 2026 Results
Aug 6, 2026 04:05PM Castellum Announces Second Quarter and First Half 2026 Financial Results
Aug 6, 2026 04:05PM Caring Brands Provides Intellectual Property Portfolio Update
Aug 6, 2026 04:05PM Nature's Sunshine Reports Second Quarter 2026 Results
Aug 6, 2026 04:05PM Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
Aug 6, 2026 04:05PM Silvaco Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM INNOVATE Corp. Announces Second Quarter 2026 Results
Aug 6, 2026 04:05PM Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance
Aug 6, 2026 04:05PM Synaptics Reports Fourth Quarter and Full Year Fiscal 2026 Results
Aug 6, 2026 04:05PM Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
Aug 6, 2026 04:05PM Phunware Reports Second Quarter 2026 Financial Results
Aug 6, 2026 04:05PM Full House Resorts Announces Strong Second Quarter Results
View Older Stories